SBIO ETF (ALPS Medical Breakthroughs ETF) is managed by ALPS Advisors with $138.5M in net assets. SBIO expense ratio is 0.50%, holding 90 positions across sectors including Health Care, Unknown, Other. Inception date: 2014-12-30.

SBIO performance shows a YTD return of 2.63%. The 1-year return is 64.54% and the 5-year return is -0.63%.

SBIO top holdings include Kymera Therapeutics Inccommon Stock (3.9%), Alkermes Plc (3.6%), Mirum Pharmaceuticals Inc (3.4%), Celcuity Inc Com (3.2%), Structure Therapeutics Inc ADR USD.0001 (3.2%). View all SBIO holdings, sector breakdown, or dividend history.

SBIO can be compared against other funds using the overlap calculator or side-by-side comparison tool. SBIO alternatives are available via the screener, along with tax-loss harvesting opportunities.